Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    larazotide
Show Display Options
Rank Status Study
1 Completed A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide Acetate 0.5 mg;   Drug: Larazotide Acetate 1 mg;   Drug: Larazotide Acetate 2 mg;   Drug: placebo
2 Completed Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate (AT-1001) in Active Celiac Disease
Condition: Celiac Disease
Interventions: Drug: larazotide acetate (AT-1001);   Drug: placebo
3 Completed Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide acetate (AT1001);   Drug: Placebo

Indicates status has not been verified in more than two years